See more : Kits Eyecare Ltd. (KTYCF) Income Statement Analysis – Financial Results
Complete financial analysis of Apollo Medical Holdings, Inc. (AMEH) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Apollo Medical Holdings, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- Houghton Mifflin Harcourt Company (HMHC) Income Statement Analysis – Financial Results
- Colombier Acquisition Corp. (CLBR) Income Statement Analysis – Financial Results
- Idogen AB (publ) (IDOGEN.ST) Income Statement Analysis – Financial Results
- Intact Gold Corp. (ITTGF) Income Statement Analysis – Financial Results
- Plutus PowerGen Plc (PPG.L) Income Statement Analysis – Financial Results
Apollo Medical Holdings, Inc. (AMEH)
About Apollo Medical Holdings, Inc.
Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare company, provides medical care services. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. The company was founded in 1994 and is headquartered in Alhambra, California.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.14B | 773.92M | 370.25M | 560.62M | 519.91M | 356.36M | 57.43M | 44.05M | 32.99M | 10.48M | 7.78M | 5.11M | 3.90M | 2.44M | 1.06M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 944.69M | 596.14M | 348.54M | 467.81M | 361.13M | 273.45M | 48.74M | 34.00M | 22.07M | 9.08M | 6.32M | 4.13M | 3.31M | 1.81M | 1.05M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 199.48M | 177.77M | 21.71M | 92.81M | 158.78M | 82.90M | 8.69M | 10.05M | 10.92M | 1.41M | 1.46M | 978.41K | 581.86K | 627.51K | 11.25K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 17.43% | 22.97% | 5.86% | 16.56% | 30.54% | 23.26% | 15.14% | 22.81% | 33.11% | 13.43% | 18.77% | 19.14% | 14.93% | 25.70% | 1.06% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 77.67M | 62.08M | 15.59M | 41.48M | 43.35M | 26.25M | 18.58M | 16.96M | 11.28M | 5.29M | 3.52M | 1.38M | 566.65K | 694.32K | 827.29K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 77.67M | 62.08M | 15.59M | 41.48M | 43.35M | 26.25M | 18.58M | 16.96M | 11.28M | 5.29M | 3.52M | 1.38M | 566.65K | 694.32K | 827.29K | 36.65K | 27.48K | 13.34K | 10.09K | 7.80K |
| Other Expenses | 3.94M | -3.75M | 7.69M | 3.03M | 1.62M | 168.10K | 14.70K | 239.06K | 3.03K | 49.70K | -37.25K | 2.84K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 95.21M | 79.59M | 15.62M | 58.40M | 66.55M | 45.32M | 19.23M | 17.31M | 11.62M | 5.32M | 3.54M | 1.39M | 577.85K | 730.02K | 847.07K | 36.65K | 27.48K | 13.34K | 10.09K | 7.80K |
| Cost & Expenses | 1.04B | 675.74M | 364.16M | 526.20M | 427.68M | 318.78M | 67.96M | 51.31M | 33.68M | 14.39M | 9.85M | 5.52M | 3.89M | 2.54M | 1.89M | 36.65K | 27.48K | 13.34K | 10.09K | 7.80K |
| Interest Income | 1.98M | 1.57M | 405.00K | 2.02M | 1.26M | 1.02M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 7.92M | 5.39M | 2.53M | 4.73M | 561.00K | 79.69K | 82.91K | 542.30K | 1.33M | 679.18K | 930.18K | 304.03K | 126.43K | 53.13K | 55.20K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 29.09M | 11.03M | 25.93M | 18.43M | 19.30M | 19.08M | 351.40K | 351.40K | 334.43K | 31.36K | 20.92K | 12.59K | 11.20K | 35.70K | 19.78K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | 133.35M | 111.40M | 40.27M | 50.85M | 106.29M | 56.72M | -9.88M | -6.68M | -356.87K | -3.83M | -2.09M | -397.90K | 15.21K | -66.81K | -816.04K | -36.65K | -27.48K | -13.34K | -10.09K | -7.80K |
| EBITDA Ratio | 11.65% | 14.39% | 10.88% | 9.07% | 20.44% | 15.92% | -17.20% | -15.16% | -1.08% | -36.52% | -26.94% | -7.79% | 0.39% | -2.74% | -77.18% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | 104.27M | 98.18M | 6.09M | 32.42M | 88.43M | 35.15M | -10.54M | -7.27M | -694.33K | -3.91M | -2.08M | -413.34K | 4.02K | -102.52K | -835.82K | -36.65K | -27.48K | -13.34K | -10.09K | -7.80K |
| Operating Income Ratio | 9.11% | 12.69% | 1.64% | 5.78% | 17.01% | 9.86% | -18.35% | -16.50% | -2.10% | -37.29% | -26.73% | -8.09% | 0.10% | -4.20% | -79.05% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -17.65M | -20.43M | 2.78M | -8.57M | -9.60M | 14.57M | 1.81M | -978.30K | -489.83K | -629.48K | -6.82M | -301.19K | -158.75K | -92.77K | -55.20K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax | 86.62M | 77.75M | 8.87M | 25.84M | 82.63M | 49.71M | -8.73M | -8.24M | -1.18M | -4.54M | -8.90M | -714.53K | -154.73K | -195.28K | -891.02K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | 7.57% | 10.05% | 2.40% | 4.61% | 15.89% | 13.95% | -15.20% | -18.72% | -3.59% | -43.30% | -114.45% | -13.98% | -3.97% | -8.00% | -84.27% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 40.88M | 31.69M | 9.18M | 8.17M | 22.36M | 3.89M | -47.50K | -71.04K | 163.79K | 19.51K | 4.80K | 5.82K | 1.60K | 800.00 | 800.00 | 36.65K | 27.48K | 13.34K | 10.09K | 7.80K |
| Net Income | 45.17M | 68.92M | -23.75M | 14.12M | 10.84M | 25.80M | -8.97M | -9.34M | -1.80M | -5.02M | -8.90M | -720.35K | -156.33K | -196.08K | -891.82K | -36.65K | -27.48K | -13.34K | -10.09K | -7.80K |
| Net Income Ratio | 3.95% | 8.91% | -6.42% | 2.52% | 2.08% | 7.24% | -15.62% | -21.21% | -5.46% | -47.88% | -114.51% | -14.09% | -4.01% | -8.03% | -84.34% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | 1.00 | 1.57 | -0.65 | 0.41 | 0.33 | 0.80 | -1.49 | -1.59 | -0.37 | -1.07 | -2.56 | -0.25 | -0.06 | -0.07 | -0.37 | -0.12 | -1.57 | -0.76 | -0.58 | -0.45 |
| EPS Diluted | 0.99 | 1.52 | -0.63 | 0.39 | 0.29 | 0.80 | -1.49 | -1.59 | -0.37 | -1.07 | -2.56 | -0.25 | -0.06 | -0.07 | -0.37 | -0.12 | -1.57 | -0.76 | -0.58 | -0.45 |
| Weighted Avg Shares Out | 44.97M | 43.83M | 36.53M | 34.71M | 32.89M | 32.30M | 6.03M | 5.88M | 4.86M | 4.70M | 3.48M | 2.93M | 2.75M | 2.65M | 2.40M | 299.70K | 17.51K | 17.51K | 17.51K | 17.51K |
| Weighted Avg Shares Out (Dil) | 45.60M | 43.83M | 37.45M | 36.40M | 37.91M | 32.30M | 6.03M | 5.88M | 4.86M | 4.70M | 3.48M | 2.93M | 2.75M | 2.65M | 2.40M | 299.70K | 17.51K | 17.51K | 17.51K | 17.51K |
Apollo Medical Holdings, Inc. to Participate in Upcoming Investor Conferences
ALHAMBRA, Calif. , Sept. 1, 2023 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based...
Apollo Medical Holdings Inc. (AMEH) Q2 2023 Earnings Call Transcript
Apollo Medical Holdings Inc. (NASDAQ:AMEH ) Q2 2023 Earnings Conference Call August 7, 2023 5:30 PM ET Company Participants Carolyne Sohn - Vice President of Investor Relations Brandon Sim - Co-Chief Executive Officer Chan Basho - Chief Financial Officer Conference...
Apollo Medical Holdings, Inc. (AMEH) Meets Q2 Earnings Estimates
Apollo Medical Holdings, Inc. (AMEH) came out with quarterly earnings of $0.28 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.25 per share a year ago.
Apollo Medical Holdings, Inc. Reports Second Quarter 2023 Results
Company to Host Conference Call on Monday, August 7, 2023, at 2:30 p.m. PT/5:30 p.m.
Apollo Medical Holdings, Inc. Announces Partnership with IntraCare to Advance Value-Based Care in Texas and Oklahoma
ALHAMBRA, Calif. , July 31, 2023 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of...
Apollo Medical Holdings, Inc. Schedules 2023 Second Quarter Financial Results Release and Conference Call
ALHAMBRA, Calif. , July 28, 2023 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of...
Apollo Medical Holdings, Inc. Signs Definitive Agreement to Acquire Assets of Texas Independent Providers, Expanding Care Partners Business into Houston
ALHAMBRA, Calif. , July 12, 2023 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of...
Is the Options Market Predicting a Spike in Apollo Medical (AMEH) Stock?
Investors need to pay close attention to Apollo Medical (AMEH) stock based on the movements in the options market lately.
3 Medical Services Stocks to Buy Amid Improving Industry Trends
The Zacks Medical - Services industry is growing on digital healthcare adoption. MEDP, HQY and AMEH are set to gain the most.
Wall Street Analysts Believe Apollo Medical Holdings, Inc. (AMEH) Could Rally 59.78%: Here's is How to Trade
The average of price targets set by Wall Street analysts indicates a potential upside of 59.8% in Apollo Medical Holdings, Inc. (AMEH). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might...
Source: https://incomestatements.info
Category: Stock Reports